Bordeaux, France / April 19th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs) and established a lab in Kobe Biomedical Innovation Cluster, today announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in the field of stem cell biology and regenerative medicine.
The Stem Cell Spaceshot Grant is open to PhD-level scientists and PhD students conducting research in stem cell biology, biophysics, gene editing, cell therapy, and bioproduction engineering. With this grant, TreeFrog Therapeutics aims at supporting scientific discoveries with therapeutic impact in 4 areas:
- 1. Progressing stem cell culture and cell therapy products through biomimetic strategies
- 2. Upgrading stem cell-products and manufacturing processes using new technologies and scientific approaches
- 3. Improving the quality control and safety profile of stem cells and stem cell-derived transplants
- 4. Enhancing the engraftment, integration and long-term survival of stem-cell derived transplants
To apply, researchers only need to submit an email, a one-page research project description and a graphical abstract through an online form available on the TreeFrog Therapeutics’ website. Applications will be opened from May 1st to June 30th 2022. 10 nominees will be selected in August 2022. The winner will be awarded in October 2022 following interviews with an interdisciplinary jury composed of world-class experts in stem cell biology, gene editing and biophysics.
Please apply from : https://treefrog.fr/stem-cell-spaceshot-grant/